FARE Clinical Network
A Network of Caring
The FARE Clinical Network is a coalition of top food allergy centers led and coordinated by FARE (Food Allergy Research & Education). Participating institutions collaborate to advance the field of food allergy, ensuring that patients with food allergies have access to state-of-the-art diagnosis and treatment, short-term and long-term care, and research that addresses factors from discovery to application. The FARE Clinical Network is setting the standard for breakthrough food allergy research and clinical care nationwide.
Accelerating Advances in Food Allergy Research With the Expanded FARE Clinical Network
Driving Impact on Food Allergy Research
Food allergy centers in the FARE Clinical Network have participated in more than 60 clinical trials in food allergy, including those that led to the development and market release of an FDA-approved treatment for peanut allergy in January 2020. Investigations at FARE Clinical Network sites continue to support the development of additional therapies, new diagnostics, and strategies for food allergy prevention and management. FARE Clinical Network centers have offer patient and community education and have helped to educate a new generation of allergists/immunologists and other care providers in best practices for food allergy prevention, diagnosis and treatment.
Expanding Patient Access to Care and Treatments
By increasing the locations available for multi-site clinical trials, the expanded FARE Clinical Network is facilitating the development of new therapies, diagnostics and prevention strategies and is making experimental treatments more accessible to a broader number of those living with potentially life-threatening food allergies.
Your food allergy story powers research that changes lives.
Join the FARE Patient Registry® - making a difference is easy and confidential.Join Patient Registry
New Data Leads to New Breakthroughs
All institutions participating in the expanded FARE Clinical Network are contributing to the development of the data commons via the FARE Patient Registry and the Biobank and Biomarker Discovery Center. Through privacy-protected data sharing, these unique resources will ultimately help researchers and clinicians understand why food allergy affects individuals differently, pointing the way to effective new treatments and diagnostics.
The FARE Patient Registry is a secure database of health information that allows food-allergic individuals and their caregivers to quickly, conveniently and privately share their food allergy experiences in order to help advance food allergy research.
The FARE Data Commons will be a state-of-the-art, secure, centralized food allergy patient data platform that enables medical entities around the globe to share and access privacy-protected data in one common place and collaborate to drive research forward.